Terkko Navigator / -/ Feeds / " ( ( Astrosytooma )|( Astrocytoma )|( Astrocytoma )|( Astrocytomas )|( Astroglioma )|( Ast"

Hypertrophic Olivary Degeneration Postoperatively Following Pilocytic Astrocytoma Resection

Clinical Laboratory Testing Practices in Diffuse Gliomas Prior to Publication of 2021 World Health Organization Classification of Central Nervous System Tumors

Diagnostic yield of simultaneous dynamic contrast-enhanced magnetic resonance perfusion measurements and [¹⁸F]FET PET in patients with suspected recurrent anaplastic astrocytoma and glioblastoma

Current Considerations in the Treatment of Grade 3 Gliomas

Clinical application of a highly sensitive digital PCR assay to detect a small fraction of IDH1 R132H-mutant alleles in diffuse gliomas

Global DNA methylation profiling reveals chromosomal instability in IDH-mutant astrocytomas

Resection of brain lesions with a neuroendoscopic ultrasonic aspirator— a systematic literature review

Ketogenic Metabolic Therapy for Glioma

Incidence trends of childhood central nervous system tumors in Finland 1990-2017

The Rapid Development of Glioblastoma: A Report of Two Cases

PATH-05. A RETROSPECTIVE STUDY OF TREATMENT STRATEGIES AND OUTCOMES IN WHO GRADE II AND III ISOCITRATE DEHYDROGENASE (IDH) WILD-TYPE ASTROCYTOMA

Pilocytic astrocytoma demethylation and transcriptional landscapes link bZIP transcription factors to immune response

Astrocytoma: A Hormone-Sensitive Tumor?

Anaplastic astrocytoma during pregnancy: the importance of an effective multidisciplinary approach

Anaplastic gangliogliomas of the spinal cord: a scoping review of the literature

Brain Sciences, Vol. 10, Pages 872: The Evaluation of AREG, MMP-2, CHI3L1, GFAP, and OPN Serum Combined Value in Astrocytic Glioma Patients’ Diagnosis and Prognosis

Genes, Vol. 11, Pages 1502: Establishment and Preliminary Characterization of Three Astrocytic Cells Lines Obtained from Primary Rat Astrocytes by Sub-Cloning

Identification of an m6A RNA Methylation Regulator Risk Score Model for Prediction of Clinical Prognosis in Astrocytoma

Molecular Genetic Analysis of p53 Intratumoral Heterogeneity in Human Astrocytic Brain Tumors.

Diffuse astrocytic glioma, IDH-Wildtype, with molecular features of glioblastoma, WHO grade IV: A single-institution case series and review.

The Evaluation of AREG, MMP-2, CHI3L1, GFAP, and OPN Serum Combined Value in Astrocytic Glioma Patients' Diagnosis and Prognosis.

Cancers, Vol. 13, Pages 4539: Atomic Force Microscope Nanoindentation Analysis of Diffuse Astrocytic Tumor Elasticity: Relation with Tumor Histopathology

Clinical and radiographic characteristics of diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma: a single institution review

Neuroimaging of pediatric infratentorial tumors and the value of diffusion-weighted imaging (DWI) in determining tumor grade

Twist predicts poor outcome of patients with astrocytic glioma.

LGG-51. BRAF ALTERATIONS IN PEDIATRIC LOW-GRADE GLIOMAS: RESULTS FROM A BRAZILIAN COHORT

Carbonic anhydrase II in the endothelium of glial tumors: A potential target for therapy.

The Efficacy of Everolimus for Facial Angiofibromas in Tuberous Sclerosis Complex Patients Treated for Renal Angiomyolipoma/Subependymal Giant Cell Astrocytoma.

TMOD-14. CREATION OF A GENETICALLY ENGINEERED MOUSE MODEL OF ANAPLASTIC ASTROCYTOMA DRIVEN BY THE IDH1-R132H ONCOGENE

HGG-29. A CASE OF CIRCUMSCRIBED HIGH-GRADE ASTROCYTOMA WITH ATRX AND CDKN2A/B ALTERNATIONS WHO WAS INITIALLY DIAGNOSED AS GLIOBLASTOMA AND HAS 20 YEARS SURVIVAL

Twist predicts poor outcome of patients with astrocytic glioma

Histone Mark Profiling in Pediatric Astrocytomas Reveals Prognostic Significance of H3K9 Trimethylation and Histone Methyltransferase SUV39H1

Clinical association analysis of ependymomas and pilocytic astrocytomas reveals elevated FGFR3 and FGFR1 expression in aggressive ependymomas.

Clinical association analysis of ependymomas and pilocytic astrocytomas reveals elevated FGFR3 and FGFR1 expression in aggressive ependymomas.

PATH-27. CLINICAL, RADIOLOGIC AND PROGNOSTIC PROFILE OF IDH WILD TYPE DIFFUSE ASTROCYTOMA WITH MOLECULAR FEATURES OF GLIOBLASTOMA

PATH-05. A CASE OF PILOCYTIC ASTROCYTOMA HARBORING THE FGFR1 GENE MUTATION WITH A PREDOMINANT OLIGODENDROGLIOMA-LIKE COMPONENT

IDH-wildtype glioblastomas and grade III/IV IDH-mutant gliomas show elevated tracer uptake in fibroblast activation protein-specific PET/CT.

Surgical treatment and neurological outcome of infiltrating intramedullary astrocytoma WHO II-IV: a multicenter retrospective case series.

High-resolution melting effectively pre-screens for TP53 mutations before direct sequencing in patients with diffuse glioma

Expression of KIT Receptor Tyrosine Kinase in Endothelial Cells of Juvenile Brain Tumors.

Expression of KIT Receptor Tyrosine Kinase in Endothelial Cells of Juvenile Brain Tumors.

Expression of KIT Receptor Tyrosine Kinase in Endothelial Cells of Juvenile Brain Tumors.

PATH-28. EXTENT AND PROGNOSTIC VALUE OF MGMT PROMOTOR METHYLATION DEPEND ON IDH MUTATION AND 1p19q CO-DELETION IN GLIOMA WHO GRADE II

PATH-22. COMPREHENSIVE ANALYSIS OF DIVERSE LOW-GRADE NEUROEPITHELIAL TUMORS WITH FGFR1 ALTERATIONS REVEALS A DISTINCT MOLECULAR SIGNATURE OF ROSETTE-FORMING GLIONEURONAL TUMOR

LGG-16. PILOMYXOID ASTROCYTOMA OF THE CERVICAL SPINAL CORD IN A 7-YEAR-OLD ARMENIAN BOY: A CASE REPORT

Comparative evaluation of intracranial oligodendroglioma and astrocytoma of similar grades using conventional and T1-weighted DCE-MRI

Association between IDH mutational status and tumor-associated epilepsy or venous thromboembolism in patients with grade II and III astrocytoma

Recurrent adult pilocytic astrocytoma presenting with intraventricular and leptomeningeal spread